SCHEMBL2815903

SCHEMBL2815903

CC(C)(c1ccncc1)c1ccc(N)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.52
ALDH1A1 P00352 3/20 0.52
MAPK1 P28482 2/20 0.52
TSHR P16473 2/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
LMNA P02545 1/20 0.52
CYP2D6 P10635 1/20 0.52
CHRM1 P11229 1/20 0.52
KCNA1 Q09470 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
KIF11 P52732 5/20 0.45
RAD52 P43351 1/20 0.45
RAB9A P51151 3/20 0.42
HPGD P15428 2/20 0.42
NPC1 O15118 2/20 0.42
CYP3A4 P08684 3/20 0.41
ESR1 P03372 2/20 0.41
ESR2 Q92731 2/20 0.41
AR P10275 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1729158 0.85 CYP3A4 (0.52) MAPTALDH1A1MAPK1TSHRMEN1
SCHEMBL126726 0.85 CYP3A4 (0.52) MAPTALDH1A1MAPK1TSHRMEN1
SCHEMBL6428302 0.85 KIF11 (0.50) MAPTALDH1A1MAPK1TSHRMEN1
SCHEMBL108051 0.85 CYP3A4 (0.52) MAPTALDH1A1MAPK1TSHRMEN1
Ammonia Solution, Strong SCHEMBL9579949 0.83 ALDH1A1 (0.50) MAPTALDH1A1MAPK1TSHRMEN1
Hydrochloric Acid SCHEMBL8641636 0.83 ALDH1A1 (0.50) MAPTALDH1A1MAPK1TSHRMEN1
SCHEMBL20869792 0.78 ALDH1A1 (0.46) MAPTALDH1A1MAPK1TSHRMEN1
SCHEMBL10631366 0.78 ALDH1A1 (0.46) MAPTALDH1A1MAPK1TSHRMEN1
SCHEMBL10391392 0.78 KIF11 (0.58) MAPTALDH1A1MAPK1TSHRMEN1
SCHEMBL28977900 0.78 KIF11 (0.58) MAPTALDH1A1MAPK1TSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100249123-A1 NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE ADDEX PHARMA SA (CH) 2010-09-30 US disclosed
EP-2134676-A2 NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE Addex Pharma SA (CH) 2009-12-23 EP disclosed
WO-2008117175-A2 NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE ADDEX PHARMA SA (CH) 2008-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249123-A1 NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE FSHR, GNRHR, SHBG MAPT 4813/4885ALDH1A1 1769/4885MAPK1 2373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.